Shaun Shadaker
Datos Biográficos
| ID | 7448101 |
|---|---|
| NOMBRE | Shaun Shadaker |
| NOMBRES | Shaun |
| APELLIDO | Shadaker |
| FIRMA | SHADAKER S |
| AFILIACIONES | Centers for Disease Control and Prevention |
| ORCID | 0000-0002-5772-7046 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2020 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia
We evaluated the cost and cost-effectiveness of alternative screening pathways during 2018–2022 within Georgia’s hepatitis C elimination program, which started in 2015. We calculated patient-level costs (2022 USD$) of hepatitis C treatment with centralized and decentralized diagnostic testing in hospitals, primary healthcare (PHC), harm reduction providers (HRP), or specialized providers (SP) from reimbursement records including the value of dona…
Results of the HCV self-testing implementation study through the secondary distribution of HCV self-tests among adult males in Georgia
Scaling up hepatitis C virus (HCV) testing and diagnosis is a critical goal of the Global WHO elimination strategy. HCV self-testing (HCVST) has emerged as a promising self-care approach to improve access and early detection, particularly among hard-to-reach populations. In Georgia, a 2015 HCV serosurvey indicated that 57.3% of anti-HCV reactive individuals were men aged 30–59. This study evaluated a secondary distribution strategy for HCVST aime…
Awareness, knowledge, and practices related to hepatitis B and hepatitis C in the Republic of Uzbekistan—Results from a population-based survey, 2022
Educational campaigns are needed to promote population awareness and address knowledge gaps to increase uptake of interventions aimed at eliminating viral hepatitis in Uzbekistan
Incidence of hepatitis C virus antibody seroconversion among people who inject drugs in Tbilisi, Georgia, 2017–2019
Integration of hepatitis C treatment at harm reduction centers in Georgia—Findings from a patient satisfaction survey
Sin obras prominentes en esta página.
Integration of hepatitis C treatment at harm reduction centers in Georgia—Findings from a patient satisfaction survey
Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia
We evaluated the cost and cost-effectiveness of alternative screening pathways during 2018–2022 within Georgia’s hepatitis C elimination program, which started in 2015. We calculated patient-level costs (2022 USD$) of hepatitis C treatment with centralized and decentralized diagnostic testing in hospitals, primary healthcare (PHC), harm reduction providers (HRP), or specialized providers (SP) from reimbursement records including the value of dona…
Results of the HCV self-testing implementation study through the secondary distribution of HCV self-tests among adult males in Georgia
Scaling up hepatitis C virus (HCV) testing and diagnosis is a critical goal of the Global WHO elimination strategy. HCV self-testing (HCVST) has emerged as a promising self-care approach to improve access and early detection, particularly among hard-to-reach populations. In Georgia, a 2015 HCV serosurvey indicated that 57.3% of anti-HCV reactive individuals were men aged 30–59. This study evaluated a secondary distribution strategy for HCVST aime…
Awareness, knowledge, and practices related to hepatitis B and hepatitis C in the Republic of Uzbekistan—Results from a population-based survey, 2022
Educational campaigns are needed to promote population awareness and address knowledge gaps to increase uptake of interventions aimed at eliminating viral hepatitis in Uzbekistan
Incidence of hepatitis C virus antibody seroconversion among people who inject drugs in Tbilisi, Georgia, 2017–2019
Hepatitis C (5 obras) · Hepatitis C virus research (5 obras) · Hepatitis B Virus Studies (4 obras) · Hepatitis C virus (3 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Population (3 obras) · Public health (3 obras) · Biostatistics (2 obras) · Epidemiology (2 obras) · Harm reduction (2 obras)